Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Capricor between October 9, 2024 and July 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. ("Capricor" …

Rogers Communications Inc. (NYSE:RCI ) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ET Company Participants Anthony Staffieri - President, CEO & Director Glenn A. Brandt - Chief Financial Officer Paul Carpino - Vice President of Investor Relations Conference Call Participants Aravinda Suranimala Galappatthige - Canaccord Genuity Corp., Research Division Batya Levi - UBS Investment Bank, Research Division David John McFadgen - Cormark Securities Inc., Research Division Drew McReynolds - RBC Capital Markets, Research Division Jerome Dubreuil - Desjardins Securities Inc., Research Division Maher Yaghi - Scotiabank Global Banking and Markets, Research Division Matthew Griffiths - BofA Securities, …

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PepGen To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PepGen between March 7, 2024 and March 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. ("PepGen" or …

Dow jumps on Trump's Japan trade deal, boosting Caterpillar and Boeing. Traders eye EU talks, tech earnings, and Fed signals for the next market move.

ESS may post Q2 revenue and FFO growth as West Coast demand and portfolio reallocation support higher occupancy and rents.

EWBC tops Q2 earnings estimates as net interest income and non-interest income rise. Loans and deposits also climb.

The GME stock slumps 10% in 3 months as core sales sink despite cost cuts, collectibles gains and strong cash reserves.

Lucky Strike Entertainment (LUCK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Fiserv, Inc.'s Q2 results showed slowing organic growth and margin expansion, intensifying market concerns despite strong cost controls and ongoing capital returns. Clover's growth deceleration and management's damaged credibility are key issues, but the platform remains a market share gainer with international and sector expansion potential. FI shares now reflect excessive pessimism, offering a 7% free cash flow yield and pricing in just 3% long-term growth, which I believe underestimates Fiserv's prospects.

After a nine-year hiatus, McDonald's brought back the popular Snack Wrap to overwhelming customer response, causing temporary ingredient shortages across some of its restaurants.

ET plans to invest $5 billion in 2025 to expand its pipeline and storage network, boosting scale and export reach.

INTU rolls out AI agents in its Enterprise Suite, targeting mid-market firms with smarter, automated operations.

A new trade agreement was announced that lowers tariffs on Japanese imported autos to +15% from +27.5%, with $550B in loans and investments.

PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.

SAP posts 37% EPS growth and 24% cloud revenue surge, but shares slip after mixed Q2 results and currency concerns.

Applied Digital inks a 250MW lease agreement with CoreWeave at Ellendale, cementing its role as a rising force in AI hyperscale infrastructure.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket Pharmaceuticals between February 27, 2025 and May 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Pharmaceuticals, …

Physical AI, which bridges today's digitally focused AI to machines, robots, and devices that can interact in real-time, learning and adapting along the way, is the future of AI.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Alto To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Alto (a) Alto common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about February 2, 2024 (the "IPO" or "Offering"); and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner …

This weekly update tracks some of the largest cryptocurrencies by market share: bitcoin and ether. While both are considered to be high-risk when it comes to investing, the two have foundational differences that investors should know.